id	sid	eid	entity	type
ajst-32484	1	1	111	CARDINAL
ajst-32484	1	2	ziyuan gao 1, †	PERSON
ajst-32484	1	3	yuzhu chen 2	PERSON
ajst-32484	1	4	1	CARDINAL
ajst-32484	1	5	xi'an jiaotong university	ORG
ajst-32484	1	6	xi’an shaanxi	GPE
ajst-32484	1	7	710049	DATE
ajst-32484	1	8	china 2	ORG
ajst-32484	1	9	beijing	GPE
ajst-32484	1	10	capital medical university	ORG
ajst-32484	1	11	beijing	GPE
ajst-32484	1	12	china	GPE
ajst-32484	1	13	ziyuan gao	PERSON
ajst-32484	1	14	two	CARDINAL
ajst-32484	2	1	about 60%	PERCENT
ajst-32484	4	1	alk-tkis	ORG
ajst-32484	8	1	1	CARDINAL
ajst-32484	8	2	1	CARDINAL
ajst-32484	9	1	around 60%	PERCENT
ajst-32484	9	2	2	CARDINAL
ajst-32484	10	1	50 percent	PERCENT
ajst-32484	10	2	asian	NORP
ajst-32484	10	3	10 percent	PERCENT
ajst-32484	10	4	16.6 percent	PERCENT
ajst-32484	10	5	caucasian	NORP
ajst-32484	11	1	3	CARDINAL
ajst-32484	12	1	third	ORDINAL
ajst-32484	14	1	∼7%	PERCENT
ajst-32484	14	2	4	CARDINAL
ajst-32484	15	1	5	CARDINAL
ajst-32484	16	1	alk-tkis	ORG
ajst-32484	20	1	2	CARDINAL
ajst-32484	20	2	2.1	CARDINAL
ajst-32484	22	1	first	ORDINAL
ajst-32484	22	2	second	ORDINAL
ajst-32484	23	1	6	CARDINAL
ajst-32484	23	2	third	ORDINAL
ajst-32484	23	3	7	CARDINAL
ajst-32484	24	1	5%–10%	PERCENT
ajst-32484	24	2	pi3k-akt	ORG
ajst-32484	24	3	8-10	CARDINAL
ajst-32484	24	4	112	CARDINAL
ajst-32484	25	1	sclc	GPE
ajst-32484	25	2	5%–10%	PERCENT
ajst-32484	25	3	8-11	CARDINAL
ajst-32484	26	1	2.2	CARDINAL
ajst-32484	26	2	ras/mapk	ORG
ajst-32484	26	3	pi3k/akt	ORG
ajst-32484	26	4	12	CARDINAL
ajst-32484	26	5	13	CARDINAL
ajst-32484	27	1	alk-tki	ORG
ajst-32484	27	2	g1202r+l1196m	ORG
ajst-32484	27	3	2024	CARDINAL
ajst-32484	27	4	14	CARDINAL
ajst-32484	28	1	1	CARDINAL
ajst-32484	29	1	c797s	PERSON
ajst-32484	30	1	ras/raf/mek/erk	ORG
ajst-32484	31	1	sclc/scc	ORG
ajst-32484	32	1	3	CARDINAL
ajst-32484	32	2	3.1	CARDINAL
ajst-32484	32	3	first	ORDINAL
ajst-32484	34	1	first	ORDINAL
ajst-32484	34	2	asia-pacific	LOC
ajst-32484	34	3	third	ORDINAL
ajst-32484	34	4	two	CARDINAL
ajst-32484	34	5	china	GPE
ajst-32484	34	6	csco	ORG
ajst-32484	35	1	113 3.1.1	CARDINAL
ajst-32484	37	1	third	ORDINAL
ajst-32484	37	2	30%-50%	PERCENT
ajst-32484	39	1	fourth	ORDINAL
ajst-32484	39	2	bdtx-1535	DATE
ajst-32484	39	3	c797s	ORG
ajst-32484	39	4	nct05256290	GPE
ajst-32484	39	5	42%	PERCENT
ajst-32484	39	6	15	CARDINAL
ajst-32484	41	1	16	CARDINAL
ajst-32484	41	2	17	CARDINAL
ajst-32484	42	1	18	CARDINAL
ajst-32484	42	2	five-year	DATE
ajst-32484	42	3	5-year	DATE
ajst-32484	42	4	19%	PERCENT
ajst-32484	42	5	22%	PERCENT
ajst-32484	42	6	19	CARDINAL
ajst-32484	42	7	20	CARDINAL
ajst-32484	44	1	3.1.2.2	CARDINAL
ajst-32484	45	1	29.8	CARDINAL
ajst-32484	45	2	5.5 months	DATE
ajst-32484	45	3	21].adcs	ORG
ajst-32484	45	4	trop2	ORG
ajst-32484	45	5	datopotamab deruxtecan	PERSON
ajst-32484	47	1	22	CARDINAL
ajst-32484	47	2	23	CARDINAL
ajst-32484	49	1	24	CARDINAL
ajst-32484	49	2	orient-31	DATE
ajst-32484	49	3	25	CARDINAL
ajst-32484	50	1	3.2	CARDINAL
ajst-32484	50	2	alk-tki	ORG
ajst-32484	51	1	3.2.1	CARDINAL
ajst-32484	53	1	12	CARDINAL
ajst-32484	53	2	13	CARDINAL
ajst-32484	53	3	i/ii	EVENT
ajst-32484	53	4	29	CARDINAL
ajst-32484	54	1	30	CARDINAL
ajst-32484	55	1	ras/mapk	ORG
ajst-32484	55	2	pi3k/akt	ORG
ajst-32484	56	1	12	CARDINAL
ajst-32484	56	2	13	DATE
ajst-32484	56	3	29	DATE
ajst-32484	57	1	25%-47%	PERCENT
ajst-32484	58	1	114	CARDINAL
ajst-32484	58	2	1	CARDINAL
ajst-32484	58	3	first	ORDINAL
ajst-32484	58	4	second	ORDINAL
ajst-32484	59	1	26	CARDINAL
ajst-32484	59	2	apollo	ORG
ajst-32484	59	3	ⅱ	CARDINAL
ajst-32484	59	4	orr:68.9%	PERCENT
ajst-32484	59	5	3	CARDINAL
ajst-32484	60	1	third	ORDINAL
ajst-32484	61	1	15	CARDINAL
ajst-32484	61	2	bdtx-1535	DATE
ajst-32484	61	3	aes	ORG
ajst-32484	63	1	16	CARDINAL
ajst-32484	63	2	ⅱ	CARDINAL
ajst-32484	63	3	3	CARDINAL
ajst-32484	63	4	30%	PERCENT
ajst-32484	63	5	30%	PERCENT
ajst-32484	63	6	17	CARDINAL
ajst-32484	63	7	ⅱ	CARDINAL
ajst-32484	63	8	mpfs:5.6 mo	GPE
ajst-32484	63	9	3	CARDINAL
ajst-32484	63	10	34%	PERCENT
ajst-32484	63	11	29%	PERCENT
ajst-32484	64	1	18	CARDINAL
ajst-32484	64	2	ⅱ	CARDINAL
ajst-32484	64	3	5.4mg/kg	QUANTITY
ajst-32484	64	4	6.4mg/kg	QUANTITY
ajst-32484	64	5	orr	PERSON
ajst-32484	64	6	5.4mg/kg	QUANTITY
ajst-32484	64	7	5.4mg/kg	QUANTITY
ajst-32484	64	8	6.4mg/kg	QUANTITY
ajst-32484	64	9	3	CARDINAL
ajst-32484	64	10	5.4mg/kg	QUANTITY
ajst-32484	65	1	19	CARDINAL
ajst-32484	65	2	20	DATE
ajst-32484	65	3	27	CARDINAL
ajst-32484	65	4	ⅱ	CARDINAL
ajst-32484	67	1	b:9.7mo c:10.9mo orr:	PERSON
ajst-32484	67	2	a:33%	GPE
ajst-32484	70	1	21	CARDINAL
ajst-32484	70	2	ⅱ	CARDINAL
ajst-32484	70	3	mpfs:5.5	GPE
ajst-32484	70	4	orr:29.8%	PERCENT
ajst-32484	70	5	mos:11.9 mo grade	GPE
ajst-32484	70	6	3 teae	QUANTITY
ajst-32484	70	7	64.9%	PERCENT
ajst-32484	70	8	40%	PERCENT
ajst-32484	70	9	trop2	ORG
ajst-32484	71	1	28	CARDINAL
ajst-32484	71	2	4.4	CARDINAL
ajst-32484	71	3	3.7	CARDINAL
ajst-32484	71	4	b:12.8%	PERCENT
ajst-32484	71	5	3	CARDINAL
ajst-32484	71	6	25%	PERCENT
ajst-32484	71	7	41%	PERCENT
ajst-32484	71	8	10%	PERCENT
ajst-32484	71	9	12%	PERCENT
ajst-32484	71	10	22	CARDINAL
ajst-32484	72	1	pemetrexed	ORG
ajst-32484	72	2	50%	PERCENT
ajst-32484	73	1	11	CARDINAL
ajst-32484	73	2	14.0 months	DATE
ajst-32484	74	1	3	CARDINAL
ajst-32484	74	2	70%	PERCENT
ajst-32484	74	3	25%	PERCENT
ajst-32484	74	4	25%	PERCENT
ajst-32484	75	1	24	CARDINAL
ajst-32484	76	1	abcp:10.2mo mos: acp:19.0mo bcp:18.1mo	PERSON
ajst-32484	76	2	3	CARDINAL
ajst-32484	76	3	56.8%	PERCENT
ajst-32484	76	4	55.8%	PERCENT
ajst-32484	76	5	66.7%	PERCENT
ajst-32484	77	1	25	CARDINAL
ajst-32484	77	2	sintilimab+	ORG
ajst-32484	77	3	7.2	CARDINAL
ajst-32484	77	4	5.5	CARDINAL
ajst-32484	77	5	4.3	CARDINAL
ajst-32484	77	6	3	CARDINAL
ajst-32484	77	7	56%	PERCENT
ajst-32484	77	8	41%	PERCENT
ajst-32484	77	9	49%	PERCENT
ajst-32484	77	10	115 3.2.2	CARDINAL
ajst-32484	77	11	alk-tki	ORG
ajst-32484	77	12	alk-tkis	ORG
ajst-32484	78	1	alk-dependent	PERSON
ajst-32484	78	2	32	CARDINAL
ajst-32484	79	1	pi3k	GPE
ajst-32484	79	2	2024	CARDINAL
ajst-32484	79	3	14	CARDINAL
ajst-32484	79	4	alk-tkis	ORG
ajst-32484	79	5	mek	ORG
ajst-32484	79	6	37	CARDINAL
ajst-32484	79	7	38	CARDINAL
ajst-32484	80	1	lorlatinib	PERSON
ajst-32484	80	2	39	CARDINAL
ajst-32484	80	3	40	CARDINAL
ajst-32484	81	1	2	CARDINAL
ajst-32484	81	2	alk mutant metastatic nsclc	ORG
ajst-32484	81	3	first	ORDINAL
ajst-32484	82	1	41	CARDINAL
ajst-32484	82	2	ⅱ	CARDINAL
ajst-32484	82	3	capmatinib mpfs	PERSON
ajst-32484	82	4	9.69	CARDINAL
ajst-32484	82	5	5.42	CARDINAL
ajst-32484	82	6	mo orr:	PERSON
ajst-32484	82	7	67.9%	PERCENT
ajst-32484	82	8	40.6%	PERCENT
ajst-32484	82	9	20.82	CARDINAL
ajst-32484	82	10	13.56	CARDINAL
ajst-32484	83	1	30	CARDINAL
ajst-32484	83	2	ⅱ	CARDINAL
ajst-32484	83	3	51.4%	PERCENT
ajst-32484	83	4	18.0 months	DATE
ajst-32484	83	5	11.2 months	DATE
ajst-32484	83	6	19.6 months	DATE
ajst-32484	84	1	3	CARDINAL
ajst-32484	84	2	28.2%	PERCENT
ajst-32484	85	1	second	ORDINAL
ajst-32484	86	1	39	CARDINAL
ajst-32484	86	2	ⅱ	CARDINAL
ajst-32484	86	3	1	CARDINAL
ajst-32484	86	4	alk-tki	ORG
ajst-32484	86	5	39.6%	PERCENT
ajst-32484	86	6	9.6 months	DATE
ajst-32484	86	7	6.6 months	DATE
ajst-32484	86	8	20.7 months	DATE
ajst-32484	87	1	hypertriglyceridemia	PERSON
ajst-32484	87	2	1-2	CARDINAL
ajst-32484	88	1	40	CARDINAL
ajst-32484	88	2	ⅱ	CARDINAL
ajst-32484	88	3	53%	PERCENT
ajst-32484	88	4	16.7 months	DATE
ajst-32484	89	1	1-2	CARDINAL
ajst-32484	89	2	4	CARDINAL
ajst-32484	94	1	dtp	ORG
ajst-32484	94	2	42	CARDINAL
ajst-32484	94	3	gpx4	ORG
ajst-32484	94	4	nrf2	PERSON
ajst-32484	95	1	dtp	ORG
ajst-32484	97	1	116 5	CARDINAL
ajst-32484	100	1	dtp	ORG
ajst-32484	103	1	yuzhu chen	PERSON
ajst-32484	104	1	ziyuan gao	PERSON
ajst-32484	107	1	1	CARDINAL
ajst-32484	107	2	f.	PERSON
ajst-32484	107	3	36	CARDINAL
ajst-32484	107	4	185	CARDINAL
ajst-32484	108	1	j clin	PERSON
ajst-32484	108	2	2018	DATE
ajst-32484	109	1	68(6	CARDINAL
ajst-32484	109	2	394	CARDINAL
ajst-32484	110	1	2	CARDINAL
ajst-32484	111	1	baltimore	GPE
ajst-32484	111	2	2023	CARDINAL
ajst-32484	113	1	3	CARDINAL
ajst-32484	113	2	wu	PERSON
ajst-32484	113	3	l.	PERSON
ajst-32484	113	4	egfr tkis	ORG
ajst-32484	113	5	third	ORDINAL
ajst-32484	114	1	oncol, 2020	DATE
ajst-32484	115	1	10	CARDINAL
ajst-32484	115	2	602762	CARDINAL
ajst-32484	116	1	4	CARDINAL
ajst-32484	116	2	e.	PERSON
ajst-32484	116	3	c.m. bestvina	PERSON
ajst-32484	116	4	un	ORG
ajst-32484	117	1	2022	CARDINAL
ajst-32484	118	1	12	CARDINAL
ajst-32484	118	2	1004198	CARDINAL
ajst-32484	119	1	5	CARDINAL
ajst-32484	119	2	herbst	GPE
ajst-32484	119	3	r.s.	GPE
ajst-32484	119	4	d. morgensztern	PERSON
ajst-32484	120	1	2018	DATE
ajst-32484	121	1	553(7689	CARDINAL
ajst-32484	122	1	446	CARDINAL
ajst-32484	123	1	6	CARDINAL
ajst-32484	123	2	c.h.	GPE
ajst-32484	124	1	a, 2008	DATE
ajst-32484	125	1	105(6	DATE
ajst-32484	125	2	2070	CARDINAL
ajst-32484	126	1	7	CARDINAL
ajst-32484	126	2	third	ORDINAL
ajst-32484	126	3	fourth	ORDINAL
ajst-32484	127	1	2017	CARDINAL
ajst-32484	128	1	142	CARDINAL
ajst-32484	129	1	32	CARDINAL
ajst-32484	130	1	8	CARDINAL
ajst-32484	130	2	h.a.	GPE
ajst-32484	130	3	155	CARDINAL
ajst-32484	131	1	clin cancer res	ORG
ajst-32484	131	2	2013	DATE
ajst-32484	132	1	19(8	CARDINAL
ajst-32484	132	2	2240	CARDINAL
ajst-32484	133	1	9	CARDINAL
ajst-32484	133	2	j.a.	GPE
ajst-32484	133	3	erbb3	GPE
ajst-32484	134	1	2007	DATE
ajst-32484	135	1	316(5827	TIME
ajst-32484	135	2	1039-43	CARDINAL
ajst-32484	136	1	10	CARDINAL
ajst-32484	137	1	a, 2007	DATE
ajst-32484	138	1	104(52	ORDINAL
ajst-32484	138	2	20932	CARDINAL
ajst-32484	138	3	117	CARDINAL
ajst-32484	138	4	11	CARDINAL
ajst-32484	138	5	j.k.	GPE
ajst-32484	139	1	j clin oncol	PERSON
ajst-32484	139	2	2017	DATE
ajst-32484	140	1	3065	CARDINAL
ajst-32484	141	1	12	CARDINAL
ajst-32484	141	2	14	CARDINAL
ajst-32484	142	1	clin cancer res	ORG
ajst-32484	142	2	2020	DATE
ajst-32484	143	1	26(11	CARDINAL
ajst-32484	143	2	2615-2625	CARDINAL
ajst-32484	144	1	13	CARDINAL
ajst-32484	144	2	r.	NORP
ajst-32484	144	3	14	CARDINAL
ajst-32484	145	1	clin	PERSON
ajst-32484	145	2	2021	CARDINAL
ajst-32484	146	1	799	CARDINAL
ajst-32484	147	1	14	CARDINAL
ajst-32484	147	2	b.j.	GPE
ajst-32484	147	3	lorlatinib versus	PERSON
ajst-32484	147	4	5-year	DATE
ajst-32484	148	1	j clin oncol	PERSON
ajst-32484	148	2	2024	DATE
ajst-32484	149	1	3400	CARDINAL
ajst-32484	150	1	15	CARDINAL
ajst-32484	150	2	bdtx-1535	DATE
ajst-32484	151	1	2022	CARDINAL
ajst-32484	151	2	https://clinicaltrials.gov/study/nct05256290	GPE
ajst-32484	152	1	16	CARDINAL
ajst-32484	152	2	h.a.	GPE
ajst-32484	152	3	first	ORDINAL
ajst-32484	153	1	clin lung	PERSON
ajst-32484	153	2	2021	CARDINAL
ajst-32484	154	1	22(6	CARDINAL
ajst-32484	155	1	601	CARDINAL
ajst-32484	156	1	17	CARDINAL
ajst-32484	156	2	wu	PERSON
ajst-32484	156	3	y.l.	GPE
ajst-32484	156	4	first	ORDINAL
ajst-32484	156	5	2	CARDINAL
ajst-32484	156	6	2	CARDINAL
ajst-32484	157	1	2024	DATE
ajst-32484	158	1	25(8	DATE
ajst-32484	158	2	989	CARDINAL
ajst-32484	159	1	18	CARDINAL
ajst-32484	159	2	k.	PERSON
ajst-32484	160	1	j clin oncol	PERSON
ajst-32484	160	2	2023	CARDINAL
ajst-32484	161	1	4852-4863	CARDINAL
ajst-32484	162	1	19	CARDINAL
ajst-32484	162	2	d.	NORP
ajst-32484	162	3	2	CARDINAL
ajst-32484	163	1	2016	DATE
ajst-32484	164	1	17(5	CARDINAL
ajst-32484	165	1	642-50	CARDINAL
ajst-32484	166	1	20	CARDINAL
ajst-32484	166	2	d.	NORP
ajst-32484	166	3	2	CARDINAL
ajst-32484	167	1	2017	DATE
ajst-32484	169	1	1307	CARDINAL
ajst-32484	170	1	21	CARDINAL
ajst-32484	170	2	h.a.	GPE
ajst-32484	170	3	herthena-lung01	ORG
ajst-32484	171	1	j clin oncol	PERSON
ajst-32484	171	2	2023	CARDINAL
ajst-32484	172	1	5363-5375	DATE
ajst-32484	173	1	22	CARDINAL
ajst-32484	173	2	s.h.	GPE
ajst-32484	173	3	ma13.06	DATE
ajst-32484	174	1	2023	CARDINAL
ajst-32484	175	1	18(11	DATE
ajst-32484	177	1	23	CARDINAL
ajst-32484	177	2	r.j.	PERSON
ajst-32484	177	3	tatton	PERSON
ajst-32484	178	1	2023	CARDINAL
ajst-32484	180	1	98	CARDINAL
ajst-32484	181	1	24] nogami	DATE
ajst-32484	181	2	n.	PERSON
ajst-32484	182	1	j thorac oncol	PERSON
ajst-32484	182	2	2022	CARDINAL
ajst-32484	183	1	17(2	ORDINAL
ajst-32484	183	2	309	CARDINAL
ajst-32484	184	1	25	CARDINAL
ajst-32484	184	2	s.	PERSON
ajst-32484	184	3	orient-31	DATE
ajst-32484	184	4	second	ORDINAL
ajst-32484	184	5	3	CARDINAL
ajst-32484	185	1	lancet respir med	ORG
ajst-32484	185	2	2023	CARDINAL
ajst-32484	186	1	11(7	DATE
ajst-32484	186	2	624	CARDINAL
ajst-32484	187	1	26	CARDINAL
ajst-32484	187	2	j.c.	GPE
ajst-32484	188	1	j med,	PERSON
ajst-32484	188	2	2018	DATE
ajst-32484	189	1	378(2	DATE
ajst-32484	189	2	113	CARDINAL
ajst-32484	190	1	27	CARDINAL
ajst-32484	190	2	l.	PERSON
ajst-32484	190	3	fda	ORG
ajst-32484	191	1	2018	DATE
ajst-32484	192	1	23(6	CARDINAL
ajst-32484	193	1	740	CARDINAL
ajst-32484	194	1	28	CARDINAL
ajst-32484	194	2	m.j.	PERSON
ajst-32484	194	3	datopotamab deruxtecan	PERSON
ajst-32484	195	1	j clin oncol	PERSON
ajst-32484	195	2	2025	DATE
ajst-32484	196	1	43(3	CARDINAL
ajst-32484	196	2	260	CARDINAL
ajst-32484	197	1	29	CARDINAL
ajst-32484	197	2	14	CARDINAL
ajst-32484	198	1	2022	CARDINAL
ajst-32484	199	1	15(1	CARDINAL
ajst-32484	199	2	79	CARDINAL
ajst-32484	200	1	118	CARDINAL
ajst-32484	201	1	30	CARDINAL
ajst-32484	201	2	asian	NORP
ajst-32484	201	3	14	CARDINAL
ajst-32484	202	1	2024	DATE
ajst-32484	203	1	130(10	DATE
ajst-32484	203	2	1679	CARDINAL
ajst-32484	204	1	31	CARDINAL
ajst-32484	204	2	14	CARDINAL
ajst-32484	205	1	j thorac oncol	PERSON
ajst-32484	205	2	2020	DATE
ajst-32484	206	1	15(5	CARDINAL
ajst-32484	207	1	741	CARDINAL
ajst-32484	208	1	32	CARDINAL
ajst-32484	208	2	shiba-ishii, a.	ORG
ajst-32484	209	1	nat	ORG
ajst-32484	209	2	2022	CARDINAL
ajst-32484	209	3	3(6	CARDINAL
ajst-32484	209	4	710	CARDINAL
ajst-32484	210	1	33	CARDINAL
ajst-32484	210	2	shaw	ORG
ajst-32484	210	3	a.t.	GPE
ajst-32484	211	1	j clin oncol	PERSON
ajst-32484	211	2	2019	DATE
ajst-32484	212	1	1370	CARDINAL
ajst-32484	213	1	34	CARDINAL
ajst-32484	213	2	j.f.	GPE
ajst-32484	213	3	second	ORDINAL
ajst-32484	214	1	2016	DATE
ajst-32484	215	1	6(10	CARDINAL
ajst-32484	216	1	1118	CARDINAL
ajst-32484	217	1	35	CARDINAL
ajst-32484	217	2	i.	PERSON
ajst-32484	218	1	clin cancer res	ORG
ajst-32484	218	2	2019	DATE
ajst-32484	219	1	25(22	CARDINAL
ajst-32484	219	2	6662-6670	CARDINAL
ajst-32484	220	1	36	CARDINAL
ajst-32484	220	2	s.	PERSON
ajst-32484	221	1	2018	DATE
ajst-32484	221	2	8(6	CARDINAL
ajst-32484	221	3	714	CARDINAL
ajst-32484	222	1	37	CARDINAL
ajst-32484	222	2	a.s.	GPE
ajst-32484	223	1	2014	DATE
ajst-32484	224	1	346(6216	CARDINAL
ajst-32484	224	2	1480	CARDINAL
ajst-32484	225	1	38	CARDINAL
ajst-32484	226	1	nat med,	PERSON
ajst-32484	226	2	2015	DATE
ajst-32484	227	1	21(9	DATE
ajst-32484	227	2	1038	CARDINAL
ajst-32484	228	1	39	CARDINAL
ajst-32484	228	2	kim	PERSON
ajst-32484	228	3	d.w.	GPE
ajst-32484	229	1	j clin oncol	PERSON
ajst-32484	229	2	2017	DATE
ajst-32484	230	1	35	CARDINAL
ajst-32484	230	2	22	DATE
ajst-32484	230	3	2490	CARDINAL
ajst-32484	231	1	40	CARDINAL
ajst-32484	231	2	second	ORDINAL
ajst-32484	231	3	alk tkis	ORG
ajst-32484	232	1	ann oncol	PERSON
ajst-32484	232	2	2021	DATE
ajst-32484	233	1	32(5	CARDINAL
ajst-32484	233	2	620	CARDINAL
ajst-32484	234	1	41	CARDINAL
ajst-32484	234	2	j.	PERSON
ajst-32484	234	3	14-mutated	QUANTITY
ajst-32484	234	4	2	CARDINAL
ajst-32484	235	1	lancet oncol	PRODUCT
ajst-32484	235	2	2024	DATE
ajst-32484	236	1	25(10	CARDINAL
ajst-32484	236	2	1357	CARDINAL
ajst-32484	237	1	42	CARDINAL
ajst-32484	237	2	h.q.	GPE
ajst-32484	238	1	2024	DATE
ajst-32484	239	1	39	CARDINAL
ajst-32484	240	1	101821	DATE